Join the club for FREE to access the whole archive and other member benefits.

Calico

Combating aging and associated diseases. An Alphabet (Google) subsidiary.

Founded in 2013 by Bill Maris.

Calico is a research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place.

Chief scientist, David Botstein, retired late 2022.

Visit website: https://www.calicolabs.com/

 calico-life-sciences-llc

 calico

Details last updated 04-Feb-2019

Calico News

Mapping gene function at scale: A new CRISPR imaging breakthrough

Mapping gene function at scale: A new CRISPR imaging breakthrough

Broad Institute - 27-Jan-2025

PERISCOPE links genes to cell structure, revealing new insights

ALS drug trials face setbacks but offer glimmers of hope

ALS drug trials face setbacks but offer glimmers of hope

FierceBiotech - 07-Jan-2025

Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies

Terray raised $120 million to advance AI-driven drug discovery

Terray raised $120 million to advance AI-driven drug discovery

Longevity Technology - 21-Oct-2024

Their partnership with Calico focuses on age-related disease treatments

Calico and AbbVie discover potential first-in-class cancer immunotherapy

Calico and AbbVie discover potential first-in-class cancer immunotherapy

Calico - 04-Oct-2023

ABBV-CLS-484 enhances anti-tumor immunity and is currently in clinical trials

Mitochondria-targeted compound prevents and treats metabolic syndrome in mice

Mitochondria-targeted compound prevents and treats metabolic syndrome in mice

Buck Institute - 07-Jul-2023

Selectively inhibits problematic free radicals - potential breakthrough in treatment of chronic diseases & ageing


Display all news

Calico Creations

IDEA: Induction dynamics gene expression atlas

Global dynamic model of transcriptional regulation in budding yeast

People at Calico

Madeleine Cule

Director of Data Science at Calico

Graham Ruby

Principal Investigator at Calico Life Sciences

Rochelle Buffenstein

Staff Scientist/ Senior Principal Investigator, Calico

Jonathan Lewis

CEO at Calico Life Sciences

Jacob Kimmel

Computational Fellow, Data Science at Calico Life Sciences

Arthur D. Levinson

CEO of Calico, Chairman of Apple Inc. and former CEO and chairman of Genentech.

Cynthia Kenyon

Calico’s vice president of aging research.

Adam Freund

Principal Investigator at Calico

Topics mentioned on this page:
Ageing Research, AI in Healthcare